Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 31, 2009

Sigma-Aldrich to Provide Gene Synthesis Services to Gene Oracle

  • Sigma-Aldrich will supply services to and exclusively provide custom oligonucleotides to Gene Oracle. The companies co-market GeneIOS gene synthesis system and services.

    Sigma-Aldrich's oligonucleotides thus becomes a key component of the Gene Oracle gene-synthesis platform. After customers design an optimized gene sequence using the GeneIOS software, Sigma-Aldrich reports that it will generate high-quality oligonucleotides that can be assembled to create synthetic genes within a single day.



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »